Get started
Author

Yasameen Abbas Humadi

Observed names: Jasmine A. Hummadi, Jasmine Abbas Humadi, Yasameen Abbas, Yasameen Abbass Hummadi, Yasameen Humadi, Yasmin Humadi
Institution: Nahrain University
ORCID: 0000-0002-0911-8318
Observed ORCID: 0000-0002-0911-8318
OpenAlex ID: A5005036318
Clinical Outcomes in Iraqi Patients with Rheumatoid Arthritis Following Earlier or Later Treatment with Etanercept
2021 · Nizar Al-Ani, Faiq Gorial, et al. · Open Access Rheumatology Research and Reviews · 14
PDF
Review of biologics, biosimilars, and intended copies in rheumatology, and current practice in Iraq
2018 · Nizar Abdulateef Al Ani, Faiq I Gorial, et al. · Open Access Rheumatology Research and Reviews · 8
PDF
Safety of COVID-19 Vaccine in Patients with Rheumatic and Musculoskeletal Diseases
2024 · Ali Abdulrahman Younis, Asal Adnan Ridha, et al. · Mediterranean Journal of Rheumatology · 5
The Use of Biosimilars in the Middle East: Review Article
2018 · Nazar AbdulLateef Jassim, Yasameen Abbas Humadi · Current Rheumatology Reports · 5
Serum Interleukin-6 is associated with hypocalcemia, hypoferritinemia and hyperkalemia in end-stage renal disease patients
2023 · Ghassaq Alubaidi, Yasameen Humadi, et al. · Italian Journal of Medicine · 4
PDF
Level of Interleukin-35, Interleukin-36, and the Interleukin-35/Interleukin-36 Ratio in Juvenile Idiopathic Arthritis
2021 · Qudus W. Jamal, Ghassaq Alubaidi, et al. · Open Access Macedonian Journal of Medical Sciences · 4
PDF
Interstitial Lung Disease and Pulmonary Arterial Hypertension Screening Practices in Systemic Sclerosis: Survey Insights of Rheumatologists in the Middle East and North Africa Region
2025 · Rajaie Namas, Sarah Al Qassimi, et al. · Mediterranean Journal of Rheumatology · 2
PDF
Impact of Interleukin-6 Serum Levels and rs1800795 Promoter Polymorphism on Disease Activity and Tumor Necrosis Factor Inhibitor Efficacy in Rheumatoid Arthritis
2025 · Ahmed Hilal Kamel, Ahmed Abdul-Hassan Abbas, et al. · Al-Rafidain Journal of Medical Sciences · 2
PDF
Attitude of Iraqi Rheumatologists While Managing Rheumatic Diseases in the Era of COVID-19: An Online Survey
2020 · Nizar Abdulateef Jassim, Dina Yasiry, et al. · Mediterranean Journal of Rheumatology · 2
PDF
Prevalence of Fibromyalgia in Infertile Women
2019 · Russul A. Shakir, Ala H. Badr, et al. · Journal of the Faculty of Medicine Baghdad · 2
PDF
Perceptions and clinical use of biosimilars among rheumatologists in ArLAR countries: a cross-sectional survey
2026 · Asal Adnan, Nabaa Ihsan Awadh, et al. · Frontiers in Medicine · 1
PDF
Decoding eQTLs: unraveling their role in spondyloarthropathies pathogenesis and potential therapeutics
2025 · Nabaa Ihsan Awadh, Asal Adnan Ridha, et al. · Frontiers in Immunology · 1
PDF
A 5 item version of the Workplace Activity Limitation Scale successfully identifies impaired work productivity in rheumatoid arthritis patients: A split‐sample factor analysis approach
2023 · Faiq I. Gorial, Nabaa Ihsan Awadh, et al. · International Journal of Rheumatic Diseases · 1
Iraqi Registry Data Proves Safety and Efficacy of switching to Adalimumab Biosimilar in Treating Rheumatoid Arthritis
2024 · Yasameen Abbas, Nabaa Ihsan, et al. · AL-Kindy College Medical Journal
Evaluation of oral health-related quality of life in a sample of Iraqi patients with rheumatoid arthritis: a case-control study
2024 · Khalid Burhan Khalid, Yasameen Abbas Humadi, et al. · Journal of Oral Medicine and Oral Surgery
PDF
Patient registry data on the efficacy and tolerability of adalimumab biosimilar in ankylosing spondylitis: A retrospective multicenter observational study
2023 · Nabaa Ihsan Awadh, Faiq I. Gorial, et al. · Arab Journal of Rheumatology
Works count: 16
Citation count: 51
H-index: 4
I10-index: 1
Year
Topic
Type